Successful Surgery for Cell-based Heart Valve Developed in China
- EB Virus Could Be Infected by Kiss: A Hidden Threat Linked to Cancer
- The Silent Threat: How Gas Stoves Pollute Our Homes and Impact Health
- Paternal Microbiome Perturbations Impact Offspring Fitness
- New Report Casts Doubt on Maradona’s Cause of Death and Rocks Manslaughter Case
- Chinese academician unable to provide the exact source of liver transplants
- Early Biomarker for Multiple Sclerosis Development Identified Years in Advance
Successful Surgery for Cell-based Heart Valve Developed in China
- AstraZeneca Admits for the First Time that its COVID Vaccine Has Blood Clot Side Effects
- Was COVID virus leaked from the Chinese WIV lab?
- HIV Cure Research: New Study Links Viral DNA Levels to Spontaneous Control
- FDA has mandated a top-level black box warning for all marketed CAR-T therapies
- Can people with high blood pressure eat peanuts?
- What is the difference between dopamine and dobutamine?
- How long can the patient live after heart stent surgery?
Successful Surgery for Cell-based Heart Valve Developed in China
On December 16, a recent post-operative examination of a patient who underwent heart valve replacement surgery in China revealed the growth of new cells on the replaced valve.
The surgery was performed on a 13-year-old patient with congenital heart disease, and the discovery was made during a examination conducted in Wuhan, Hubei Province, in central China.
screenshot from CGTN
Valve replacement surgery is one of the primary treatment methods for valvular heart disease. However, biological valve membranes are prone to calcification, posing a challenge in valve selection for pediatric patients. The lack of growth and development of valve membranes has been an unresolved issue in the field of cardiovascular medicine.
This year, the Tongji Hospital affiliated with Huazhong University of Science and Technology in China successfully developed a novel cell-based valve with superior biomechanical performance, self-growth, and regenerative capabilities.
This technology was first clinically applied on May 29 in a valve replacement surgery for a 13-year-old patient with congenital heart disease.
Following a colored Doppler echocardiogram and a PET-CT scan on December 7, it was determined that the artificial pulmonary artery valve functioned well, and there was a clear improvement in cardiac function. This indicates that the new cell-based pulmonary artery valve was generated within the patient’s body.
Successful Surgery for Cell-based Heart Valve Developed in China
(source:internet, reference only)
Disclaimer of medicaltrend.org
Important Note: The information provided is for informational purposes only and should not be considered as medical advice.
